Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $24.0500 (-8.94%) ($23.5200 - $26.0000) on Mon. Jan. 4, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.52% (three month average) | RSI | 36 | Latest Price | $24.0500(-8.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(53%) ARKG(50%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.76% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-8%) UNG(-3%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.76% (StdDev 7.52%) | Hourly BBV | 0 () | Intraday Trend | -6.6% | | | |
|
Resistance Level | $26.71 | 5 Day Moving Average | $24.64(-2.39%) | 10 Day Moving Average | $24.3(-1.03%) | 20 Day Moving Average | $26.71(-9.96%) | To recent high | -39.2% | To recent low | 14.5% | Market Cap | $1.787b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |